U.S. Physical Therapy, Inc.
USPH
$61.96
-$0.43-0.69%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.83% | 16.10% | 16.39% | 14.31% | 12.12% |
| Total Other Revenue | 13.49% | 17.84% | 23.27% | 26.67% | 26.38% |
| Total Revenue | 13.77% | 16.39% | 17.51% | 16.25% | 14.31% |
| Cost of Revenue | 13.57% | 16.23% | 20.68% | 18.12% | 15.83% |
| Gross Profit | 14.50% | 16.95% | 7.48% | 10.12% | 9.13% |
| SG&A Expenses | 17.93% | 18.82% | 17.81% | 17.31% | 15.85% |
| Depreciation & Amortization | 8.47% | 17.85% | -18.31% | -9.41% | 3.60% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.84% | 16.54% | 18.52% | 16.89% | 15.41% |
| Operating Income | 13.23% | 15.16% | 9.19% | 11.04% | 5.45% |
| Income Before Tax | 13.17% | 29.24% | 93.31% | 55.47% | 26.23% |
| Income Tax Expenses | 19.73% | 35.59% | 95.03% | 53.69% | 24.37% |
| Earnings from Continuing Operations | 11.05% | 27.20% | 92.76% | 56.05% | 26.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -26.79% | -29.95% | -85.47% | -73.89% | -66.07% |
| Net Income | 4.34% | 25.96% | 95.63% | 49.89% | 15.25% |
| EBIT | 13.23% | 15.16% | 9.19% | 11.04% | 5.45% |
| EBITDA | 12.53% | 16.15% | 14.69% | 15.17% | 9.76% |
| EPS Basic | -76.85% | -22.76% | 154.24% | 116.55% | 76.87% |
| Normalized Basic EPS | -1.53% | -5.47% | -27.95% | -20.35% | -22.07% |
| EPS Diluted | -76.85% | -22.76% | 154.24% | 116.55% | 76.87% |
| Normalized Diluted EPS | -1.53% | -5.47% | -27.95% | -20.35% | -22.07% |
| Average Basic Shares Outstanding | 0.60% | 0.74% | 0.78% | 0.72% | 2.83% |
| Average Diluted Shares Outstanding | 0.60% | 0.74% | 0.78% | 0.72% | 2.83% |
| Dividend Per Share | 2.26% | 2.27% | 2.29% | 2.30% | 2.31% |
| Payout Ratio | -0.01% | -0.18% | -0.47% | -0.31% | -0.05% |